BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28427520)

  • 1. Lymphoblastic lymphoma.
    Cortelazzo S; Ferreri A; Hoelzer D; Ponzoni M
    Crit Rev Oncol Hematol; 2017 May; 113():304-317. PubMed ID: 28427520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Response of Mediastinal Lymphoma to Corticosteroids During Diagnostic Evaluation: A Clinical Case Report.
    Athish KK; T J G; Padmanabha S; K R H
    Cureus; 2024 Apr; 16(4):e59103. PubMed ID: 38803712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Extramedullary Lymphoblastic Lymphoma (LBL) Diagnosed by Flowcytometric Immunophenotyping (FCI) on Fine Needle Aspirate (FNA) Sample-A Case Series of 18 Cases.
    Makde MM; Kodate PM; Kamal MM; Shroff V; Tijare JR; Kumbhalkar DT
    J Cytol; 2023; 40(3):119-125. PubMed ID: 37745809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal hyperleukocytic T lymphoblastic lymphoma/leukemia complicated with multi-gene fusion and mutation: clinical revelation and perception.
    Liu Y; Issah MA; Hu X; Shen J
    Am J Blood Res; 2020; 10(6):440-446. PubMed ID: 33489453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma.
    Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q
    Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
    Burkhardt B; Hermiston ML
    Br J Haematol; 2019 Jun; 185(6):1158-1170. PubMed ID: 30809797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
    Terwilliger T; Abdul-Hay M
    Blood Cancer J; 2017 Jun; 7(6):e577. PubMed ID: 28665419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmet needs in the first-line treatment of follicular lymphoma.
    Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
    Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?
    Gökbuget N
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):261-274. PubMed ID: 29050699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult T-Cell Leukemia/Lymphoma.
    Mehta-Shah N; Ratner L; Horwitz SM
    J Oncol Pract; 2017 Aug; 13(8):487-492. PubMed ID: 28796966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
    McNeer JL; Bleyer A
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
    Pierro J; Hogan LE; Bhatla T; Carroll WL
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):725-736. PubMed ID: 28649891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocoa, Blood Pressure, and Vascular Function.
    Ludovici V; Barthelmes J; Nägele MP; Enseleit F; Ferri C; Flammer AJ; Ruschitzka F; Sudano I
    Front Nutr; 2017; 4():36. PubMed ID: 28824916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.
    Laurent C; Baron M; Amara N; Haioun C; Dandoit M; Maynadié M; Parrens M; Vergier B; Copie-Bergman C; Fabiani B; Traverse-Glehen A; Brousse N; Copin MC; Tas P; Petrella T; Rousselet MC; Brière J; Charlotte F; Chassagne-Clement C; Rousset T; Xerri L; Moreau A; Martin A; Damotte D; Dartigues P; Soubeyran I; Peoch M; Dechelotte P; Michiels JF; de Mascarel A; Berger F; Bossard C; Arbion F; Quintin-Roué I; Picquenot JM; Patey M; Fabre B; Sevestre H; Le Naoures C; Chenard-Neu MP; Bastien C; Thiebault S; Martin L; Delage M; Filleron T; Salles G; Molina TJ; Delsol G; Brousset P; Gaulard P
    J Clin Oncol; 2017 Jun; 35(18):2008-2017. PubMed ID: 28459613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
    Vadillo E; Dorantes-Acosta E; Pelayo R; Schnoor M
    Blood Rev; 2018 Jan; 32(1):36-51. PubMed ID: 28830639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States.
    El-Fattah MA
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):498-505.e6. PubMed ID: 28647403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.
    Berry DA; Zhou S; Higley H; Mukundan L; Fu S; Reaman GH; Wood BL; Kelloff GJ; Jessup JM; Radich JP
    JAMA Oncol; 2017 Jul; 3(7):e170580. PubMed ID: 28494052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A major turning point in NK/T-cell lymphoma?
    Jaccard A; Hermine O
    Blood; 2017 Apr; 129(17):2342-2343. PubMed ID: 28450574
    [No Abstract]   [Full Text] [Related]  

  • 19. Extranodal Marginal Zone Lymphoma: No Longer Just a Sidekick.
    Kamdar MK; Smith SM
    J Clin Oncol; 2017 Jun; 35(17):1872-1878. PubMed ID: 28448239
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.